Harold Tabaie, MD
Thoracic Surgery (Cardiothoracic Vascular Surgery) · Los Angeles, CANPI 1346286663
Payments from drug & device makers
Across 271 payments — averaging $441.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Merit Medical Systems Inc$105K
- Cook Medical LLC$6K
- Terumo Medical Corporation$3K
- Cardiovascular Systems Inc.$2K
- Bard Peripheral Vascular, Inc.$979
- BD$772
- plus $2K from 12 others
What the payments were for
- Travel & lodging$3,2783%
- Food & beverage$11,0029%
- Other$105,34788%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Merit Medical Systems Inc | 1 | $105,347 |
| Cook Medical LLC | 124 | $5,651 |
| Terumo Medical Corporation | 27 | $3,184 |
| Cardiovascular Systems Inc. | 47 | $1,985 |
| Bard Peripheral Vascular, Inc. | 23 | $979 |
| BD | 9 | $772 |
| Abbott | 18 | $704 |
| Medtronic(2 entities) | 2 | $199 |
| Philips North America LLC | 3 | $142 |
| BTG International Inc. | 1 | $115 |
| Vasorum USA Inc. | 2 | $114 |
| Angiodynamics, Inc. | 2 | $112 |
| Boston Scientific | 5 | $91 |
| Cordis US CORP. | 3 | $77 |
| Argon Medical Devices, Inc. | 1 | $61 |
| Olympus Corporation Of The Americas | 1 | $49 |
| Venclose Inc. | 1 | $24 |
| Bsn Medical Inc | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Optitorque$1,552
- Heartrail$1,552
- TR Band$1,552
- Glidesheath$1,552
- Navicross$919
- AZUR$919
- GlideWire$919
- VENOVO$476
- Cook$468
- Venclose Maven Catheter$331
- ADVANCE$223
- HawkOne$141
- VARITHENA$115
How this compares
$119,626 in reported general payments places this provider in the 85th percentile of 546 thoracic surgery (cardiothoracic vascular surgery) providers in California.
See all thoracic surgery (cardiothoracic vascular surgery) providers in California →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XareltoRivaroxaban | 25 | $22,587 |
| Diclofenac Sodium | 12 | $2,345 |
| ClopidogrelClopidogrel Bisulfate | 203 | $1,963 |
| CefuroximeCefuroxime Axetil | 17 | $213 |
| Tramadol Hcl | 172 | $118 |
| Alprazolam | 105 | $37 |
Paid to pharmacies, not to this prescriber.
Other thoracic surgery (cardiothoracic vascular surgery) in Los Angeles
- Fernando FleischmanLos Angeles$901K
- Jay LeeLos Angeles$856K
- Vaughn StarnesLos Angeles$771K
- Harmik SoukiasianLos Angeles$737K
- Abbas ArdehaliLos Angeles$630K
- Richard SheminLos Angeles$392K
- Fardad EsmailianLos Angeles$356K
- Alfredo TrentoLos Angeles$335K
- Raymond LeeLos Angeles$291K
- Anthony KimLos Angeles$215K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.